Publications by authors named "Ronit Simantov"

36Publications

The Impact of Age and Gender on Outcomes of Patients With Advanced Renal Cell Carcinoma Treated With Targeted Therapy.

Clin Genitourin Cancer 2020 10 16;18(5):e598-e609. Epub 2020 Mar 16.

Department of Medicine, Division of Hematology/Oncology, University of California San Diego, Moores Cancer Center, La Jolla, CA. Electronic address:

View Article and Find Full Text PDF
October 2020

The Effect of Weight Change During Treatment With Targeted Therapy in Patients With Metastatic Renal Cell Carcinoma.

Clin Genitourin Cancer 2019 12 19;17(6):443-450.e1. Epub 2019 Jul 19.

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.

View Article and Find Full Text PDF
December 2019

Response of Primary Renal Cell Carcinoma to Systemic Therapy.

Eur Urol 2019 12 6;76(6):852-860. Epub 2019 Oct 6.

Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA; Moores Cancer Center, University of California San Diego, San Diego, CA, USA. Electronic address:

View Article and Find Full Text PDF
December 2019

Impact of Geographic Regions on Overall Survival in Patients With Metastatic Renal Cell Carcinoma: Results From an International Clinical Trials Database.

J Glob Oncol 2018 09;4:1-14

Andre P. Fay, Hospital São Lucas/Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, Brazil; Rana R. McKay, University of California San Diego, San Diego, CA; Xun Lin and Ronit Simantov, Pfizer Oncology, New York, NY; and Toni K. Choueiri, Dana-Farber Cancer Institute, Boston, MA.

View Article and Find Full Text PDF
September 2018

Characterization of Patients With Poor-Risk Metastatic Renal-Cell Carcinoma: Results From a Pooled Clinical Trials Database.

Clin Genitourin Cancer 2017 Aug 12. Epub 2017 Aug 12.

Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. Electronic address:

View Article and Find Full Text PDF
August 2017

Proton Pump Inhibitors and Survival Outcomes in Patients With Metastatic Renal Cell Carcinoma.

Clin Genitourin Cancer 2017 12 31;15(6):724-732. Epub 2017 May 31.

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA. Electronic address:

View Article and Find Full Text PDF
December 2017

Comprehensive Analysis of Survival Outcomes in Non-Clear Cell Renal Cell Carcinoma Patients Treated in Clinical Trials.

Clin Genitourin Cancer 2017 12 21;15(6):652-660.e1. Epub 2017 Mar 21.

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA. Electronic address:

View Article and Find Full Text PDF
December 2017

Estimation of tumour regression and growth rates during treatment in patients with advanced prostate cancer: a retrospective analysis.

Lancet Oncol 2017 01 13;18(1):143-154. Epub 2016 Dec 13.

Division of Medical Oncology, Department of Medicine, Columbia University/New York Presbyterian Hospital, Manhattan, NY, USA; James J Peters VA Medical Center, Bronx, NY, USA. Electronic address:

View Article and Find Full Text PDF
January 2017

Heterogeneity of Patients With Intermediate-Prognosis Metastatic Renal Cell Carcinoma Treated With Sunitinib.

Clin Genitourin Cancer 2017 04 18;15(2):291-299.e1. Epub 2016 Aug 18.

Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA.

View Article and Find Full Text PDF
April 2017

Body Mass Index and Metastatic Renal Cell Carcinoma: Clinical and Biological Correlations.

J Clin Oncol 2016 Oct;34(30):3655-3663

Laurence Albiges, Wanling Xie, Rana R. McKay, Andre P. Fay, Guillermo de Velasco, Sabina Signoretti, and Toni K. Choueiri, Dana-Farber Cancer Institute; Wanling Xie, Rana R. McKay, Mark A. Preston, Eunyoung Cho, Sabina Signoretti, and Toni K. Choueiri, Brigham and Women's Hospital; Laurence Albiges, Wanling Xie, Rana R. McKay, Andre P. Fay, Guillermo de Velasco, Eunyoung Cho, David F. McDermott, Sabina Signoretti, and Toni K. Choueiri, Harvard Medical School; Mark A. Preston and Kathryn M. Wilson, Harvard School of Public Health; David F. McDermott, Beth Israel Deaconess Medical Center, Boston, MA; Laurence Albiges, Gustave Roussy, Université Paris-Saclay, Villejuif, France; A. Ari Hakimi, Emily C. Zabor, Anders J. Skanderup, and Helena Furberg, Memorial Sloan Kettering Cancer Center, New York; Ronit Simantov and Xun Lin, Pfizer Oncology, New York, NY; Jae-Lyun Lee, University of Ulsan College of Medicine, Asan; Sun-Young Rha, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea; Brian I. Rini, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH; Sandy Srinivas, Stanford Cancer Institute, Stanford; Sumanta K. Pal, City of Hope Comprehensive Cancer Center, Duarte, CA; Georg A. Bjarnason, Sunnybrook Odette Cancer Center, Toronto; Scott Ernst, London Health Sciences Center, London, Ontario; Lori A. Wood, Queen Elizabeth II Health Sciences Center, Halifax, Nova Scotia; Daniel Y.C. Heng, Tom Baker Cancer Center; University of Calgary, Calgary, Alberta, Canada; Ulka N. Vaishamayan, Karmanos Cancer Center, Detroit, MI; Neeraj Agarwal, University of Utah Huntsman Cancer Institute, Salt Lake City, UT; Takeshi Yuasa, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan; Aristotelis Bamias, Alexandra Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece; and Eunyoung Cho, The Warren Alpert Medical School of Brown University; Brown University School of Public Health, Providence, RI.

View Article and Find Full Text PDF
October 2016

Effect of Metformin Use on Survival Outcomes in Patients With Metastatic Renal Cell Carcinoma.

Clin Genitourin Cancer 2017 04 29;15(2):221-229. Epub 2016 Jun 29.

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA. Electronic address:

View Article and Find Full Text PDF
April 2017

Statins and survival outcomes in patients with metastatic renal cell carcinoma.

Eur J Cancer 2016 Jan 11;52:155-62. Epub 2015 Dec 11.

Department of Medical Oncology, Tom Baker Cancer Center, 1331 29 Street Northwest, Calgary, AB T2N 4N2, Canada.

View Article and Find Full Text PDF
January 2016

Depth of remission is a prognostic factor for survival in patients with metastatic renal cell carcinoma.

Eur Urol 2015 May 7;67(5):952-8. Epub 2015 Jan 7.

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Electronic address:

View Article and Find Full Text PDF
May 2015

Phase I/II study of the antibody-drug conjugate glembatumumab vedotin in patients with locally advanced or metastatic breast cancer.

J Clin Oncol 2014 Nov 29;32(32):3619-25. Epub 2014 Sep 29.

Johanna Bendell and Suzanne Jones, Sarah Cannon Research Institute, Nashville, TN; Mansoor Saleh, Georgia Cancer Specialists, Atlanta, GA; April A.N. Rose and Peter M. Siegel, Goodman Cancer Research Centre, McGill University, Montreal, Quebec, Canada; Lowell Hart, Florida Cancer Specialists, Fort Myers; Surendra Sirpal, Hematology Oncology Associates, Lake Worth, FL; Jennifer Green, Elizabeth Crowley, Ronit Simantov, Tibor Keler, and Thomas Davis, Celldex Therapeutics; and Linda Vahdat, Weill Cornell Medical College, New York, NY.

View Article and Find Full Text PDF
November 2014

Phase I/II study of the antibody-drug conjugate glembatumumab vedotin in patients with advanced melanoma.

J Clin Oncol 2014 Nov 29;32(32):3659-66. Epub 2014 Sep 29.

Patrick A. Ott and Anna C. Pavlick, New York University Cancer Institute, New York, NY; Omid Hamid and Peter D. Boasberg, The Angeles Clinic and Research Institute, Los Angeles, CA; Harriet Kluger and Mario Sznol, Yale Cancer Center, New Haven, CT; Kevin B. Kim and Patrick Hwu, University of Texas MD Anderson Cancer Center, Houston, TX; Ronit Simantov, Elizabeth Crowley, Jennifer A. Green, Thomas Hawthorne, and Thomas A. Davis, Celldex Therapeutics, Hampton, NJ.

View Article and Find Full Text PDF
November 2014

Prognostic significance of bone metastases and bisphosphonate therapy in patients with renal cell carcinoma.

Eur Urol 2014 Sep 26;66(3):502-9. Epub 2014 Feb 26.

Dana-Farber Cancer Institute, Boston, MA, USA. Electronic address:

View Article and Find Full Text PDF
September 2014

GPNMB expression in uveal melanoma: a potential for targeted therapy.

Melanoma Res 2010 Jun;20(3):184-90

Department of Pathology, Section of Ophthalmology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.

View Article and Find Full Text PDF
June 2010

Discovery and development of sorafenib: a multikinase inhibitor for treating cancer.

Nat Rev Drug Discov 2006 Oct;5(10):835-44

Department of Cancer Research, Bayer Pharmaceuticals Corp., West Haven, Connecticut 06516, USA.

View Article and Find Full Text PDF
October 2006

Neprilysin inhibits angiogenesis via proteolysis of fibroblast growth factor-2.

J Biol Chem 2006 Nov 28;281(44):33597-605. Epub 2006 Aug 28.

Urologic Oncology Research Laboratory, Department of Urology, Weil Medical College of Cornell University-New York Presbyterian Hospital, New York, NY 10021, USA.

View Article and Find Full Text PDF
November 2006

Annexin II regulates fibrin homeostasis and neoangiogenesis in vivo.

J Clin Invest 2004 Jan;113(1):38-48

Department of Cell and Developmental Biology, Weill Medical College of Cornell University, New York, New York 10021, USA.

View Article and Find Full Text PDF
January 2004

Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus.

N Engl J Med 2003 Dec;349(25):2399-406

Division of Cardiology, Weill Medical College of Cornell University, the Hospital for Special Surgery, New York, NY 10021, USA.

View Article and Find Full Text PDF
December 2003

CD36: a critical anti-angiogenic receptor.

Front Biosci 2003 Sep 1;8:s874-82. Epub 2003 Sep 1.

Division of Hematology-Oncology, Weill Medical College of Cornell University, 1300 York Avenue, New York, NY 10021, USA.

View Article and Find Full Text PDF
September 2003